Older adults living in long-term care facilities experienced a similar risk of mortality and cardiovascular hospitalizations regardless of whether they were taking intensive or more moderate doses of statins, a retrospective study found.
Sleeping less than six hours a night or experiencing poor-quality rest has been independently linked to an increased risk of subclinical multiterritory atherosclerosis, a team of Spanish researchers reported in the Journal of the American College of Cardiology Jan. 14.
Medtronic announced on Jan. 15 the launch of a mobile app that connects four of the company’s pacemakers to patients’ smartphones and tablets, removing the need for bedside monitors or other remote monitoring equipment.
High retail prices for diabetes test strips are driving a “gray market” in the U.S. as an increasing number of uninsured diabetics struggle to afford something they need as often as 10 times a day, the New York Times reports.
Rivaroxaban failed to reduce the rate of early graft failure following coronary artery bypass graft (CABG) surgery compared to aspirin monotherapy, researchers reported in a substudy of the COMPASS trial published Jan. 14 in the Journal of the American College of Cardiology.
A study published online in the American Journal of Epidemiology Jan. 14 suggests any physical movement, whether it’s short, long, intense or mild, counteracts the negative cardiovascular effects of sitting for long periods.
Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.
The RAPID neuroimaging platform can now be used in the U.S. to select stroke patients who are likely to benefit from endovascular thrombectomy. It is the first imaging platform to be cleared by the FDA as a patient selection tool for this clot removal procedure, according to iSchemaView, which developed the technology.
The IN.PACT Admiral drug-coated balloon. (Photo courtesy of Medtronic)
Executives from Medtronic and Boston Scientific stood behind their companies’ paclitaxel-coated medical devices after a meta-analysis published in the Journal of the American Heart Association in December linked balloons and stents covered with the material to a significantly increased risk of death at two and five years of follow-up.
The University of Florida College of Veterinary Medicine has partnered with veterinary cardiologist Masami Uechi, DVM, PhD, to launch the country’s first open heart surgery program for dogs later this year.
